TWST
NASDAQTwist Bioscience Corporation
Price$87.53+40.27 (+85.19%)
2026-03-172026-06-18
News · 26 weeks108-56%
2025-12-282026-06-21
Mix4990d
- Insider35(71%)
- SEC Filings6(12%)
- Other4(8%)
- Earnings2(4%)
- Analyst2(4%)
Latest news
25 items- SECSEC Form S-3ASR filed by Twist Bioscience CorporationS-3ASR - Twist Bioscience Corp (0001581280) (Filer)
- INSIDERSVP of Human Resources Green Paula exercised 26,137 shares at a strike of $23.33 and sold $2,134,488 worth of shares (26,137 units at $81.67) (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- ANALYSTCanaccord Genuity initiated coverage on Twist Bioscience with a new price targetCanaccord Genuity initiated coverage of Twist Bioscience with a rating of Buy and set a new price target of $90.00
- INSIDEROfficer Cho Dennis sold $28,077 worth of shares (402 units at $69.84), decreasing direct ownership by 0.33% to 119,692 units (SEC Form 4) (tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERSVP of Human Resources Green Paula sold $61,742 worth of shares (884 units at $69.84), decreasing direct ownership by 0.73% to 120,705 units (SEC Form 4) to cover taxes4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $158,197 worth of shares (2,265 units at $69.84), decreasing direct ownership by 0.27% to 844,607 units (SEC Form 4) (for withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $94,046 worth of shares (1,359 units at $69.20) and gifted 500 shares, decreasing direct ownership by 4% to 46,327 units (SEC Form 4) (for tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Financial Officer Laponis Adam sold $280,000 worth of shares (4,000 units at $70.00) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 112,675 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $990,799 worth of shares (14,205 units at $69.75) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 120,094 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Starovasnik Melissa A. sold $170,000 worth of shares (2,500 units at $68.00) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 22,222 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. exercised 16,470 shares at a strike of $8.82 and sold $1,118,555 worth of shares (16,470 units at $67.91) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $49,987 worth of shares (800 units at $62.48), decreasing direct ownership by 2% to 48,186 units (SEC Form 4) (tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. exercised 49,299 shares at a strike of $8.82 and sold $3,213,653 worth of shares (49,299 units at $65.19) as part of a pre-agreed trading plan (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Starovasnik Melissa A. sold $30,520 worth of shares (500 units at $61.04) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 24,722 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- PRTwist Bioscience to Present at William Blair 46th Annual Growth Stock ConferenceTwist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026 at 10:00 am Central Time in Chicago, Illinois. The presentation will be webcast live and can be accessed by visiting the "Investor Calendar" page of the investor relations section of the company's website here. A replay of the presentation will be archived for a period of 30 days following the conclusion of the live events. About Twist Bioscience Corporation At Twist Bioscience,
- INSIDERSVP of Human Resources Green Paula sold $74,507 worth of shares (1,399 units at $53.26), decreasing direct ownership by 1% to 121,589 units (SEC Form 4) (for tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERPresident and COO Finn Patrick John sold $221,549 worth of shares (4,160 units at $53.26), decreasing direct ownership by 1% to 274,804 units (SEC Form 4) (withholding obligation)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDEROfficer Cho Dennis sold $87,448 worth of shares (1,642 units at $53.26), decreasing direct ownership by 1% to 134,299 units (SEC Form 4) (withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Financial Officer Laponis Adam sold $107,526 worth of shares (2,019 units at $53.26), decreasing direct ownership by 2% to 116,675 units (SEC Form 4) to satisfy withholding tax4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $36,641 worth of shares (688 units at $53.26), decreasing direct ownership by 1% to 48,986 units (SEC Form 4) (for withholding tax)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Executive Officer Leproust Emily M. sold $366,834 worth of shares (6,888 units at $53.26), decreasing direct ownership by 0.81% to 846,872 units (SEC Form 4) (tax liability)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERDirector Johannessen Jan exercised 12,000 shares at a strike of $14.00 and sold $673,440 worth of shares (12,000 units at $56.12) (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- INSIDERChief Accounting Officer Werner Robert F. sold $282,187 worth of shares (4,961 units at $56.88), decreasing direct ownership by 9% to 49,674 units (SEC Form 4)4 - Twist Bioscience Corp (0001581280) (Issuer)
- SECSEC Form 144 filed by Twist Bioscience Corporation144 - Twist Bioscience Corp (0001581280) (Subject)
- INSIDEROfficer Cho Dennis sold $112,126 worth of shares (1,962 units at $57.15), decreasing direct ownership by 1% to 135,941 units (SEC Form 4) to satisfy tax liability4 - Twist Bioscience Corp (0001581280) (Issuer)
TWST FAQ
7 questionsWhat does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with ImmunoPrecise Antibodies Ltd.; Victorian Clinical Genetic Services; Vivlion GmbH; and Kyowa Kirin Pharmaceutical Research, Inc. Twist...Where does TWST stock trade?
Twist Bioscience Corporation (TWST) is listed on NASDAQ.What sector and industry is TWST in?
Twist Bioscience Corporation operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Twist Bioscience Corporation go public?
Twist Bioscience Corporation (TWST) completed its IPO in 2018.What are analysts saying about TWST?
Twist Bioscience Corporation has had 8 recent analyst actions on file. The most recent action was from Canaccord Genuity: Buy on 2026-06-15. Recent price targets range from $2700.00 to $4500.00.What companies are similar to TWST?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare TWST side-by-side with any of them on Quantisnow.How can I track TWST on Quantisnow?
Quantisnow aggregates Twist Bioscience Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow TWST to receive live email and push alerts on every new disclosure.